Prof Elvis Terci Valera holds a Medical Degree from the University of São Paulo (1995), a Medical Residency in Childcare and Pediatrics (1995-1996), a Medical Residency in Pediatric Oncology and Hematology (1998-1999), a Masters degree in Child and Adolescent Health from the University of São Paulo (2003), and a Ph.D. in Medicine from the Childcare and Pediatrics Program at the University of São Paulo (2006). He completed a Postdoctoral Fellowship at McGill University, Montreal/Canada (2016-2017), and obtained the title of Associate Professor at the University of São Paulo in 2019. Prof. Valera is currently an Associate Professor at the Ribeirão Preto Medical School of the University of São Paulo (FMRP-USP), within the Department of Childcare and Pediatrics, since October 2023. He serves as a Graduate Program Faculty Member in the Department of Childcare and Pediatrics at the Ribeirão Preto Medical School - USP. He is the Coordinator of the Graduate Program in Child and Adolescent Health (starting in April 2024) at FMRP-USP. He is the current Coordinator of the Department of Comprehensive Care for Children and Adolescents (DAICA) - HC Criança / HCFMRP-USP (starting in August 2024). Prof. Valera has experience in Pediatric Oncology and Hematology, with an emphasis on Pediatric Neuro-Oncology, Autologous Transplantation with hematopoietic stem cell rescue (TAMO), genetics of pediatric tumors and Precision Oncology. He is a Member of the Advisory Board of the Brazilian Society of Pediatric Oncology - SOBOPE. Prof. Valera currently serves as Coordinator of the Precision Medicine Committee of SOBOPE and as the Brazilian Delegate Representative of the Latin American Society of Pediatric Oncology (SLAOP). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Medulloblastoma (MB) is the most frequent malignant brain neoplasm in children and adolescents. MB is now considered a genetically heterogeneous disease, and it is subdivided into four molecular subgroups (WNT, Shh, Group 3 and Group 4), each with its clinical and genetic characteristics. Exosomes are vesicles secreted by cells, especially under conditions of cellular stress. The exosomes…
Glioblastoma (GBM) is one of the most aggressive tumors affecting the central nervous system (CNS). It is classified in primary GBM, diagnosed primarily, and in secondary GBM, when tumor evolves from low-grade or anaplastic glial lesions. The standard treatment for GBM consists primarily of surgical resection, radiotherapy and chemotherapy (temozolomide (TMZ) and other alkylating agents).…
Introduction: Pediatric brain tumors represent a significant cause of mortality in this age group. Medulloblastoma (MB) is the most frequently occurring malignant pediatric tumor affecting the Central Nervous System (CNS). Genetically, MBs are classified into four distinct molecular subgroups (WNT, SHH, Group 3, and Group 4). Currently, the histological and molecular characteristics of MB…
Tumors of the central nervous system (CNS) are a frequent cause of death in children and adolescents. Recently, changes in epigenetic mechanisms have been implicated in the oncogenesis of high-grade gliomas (HGG) in children. Mutations in histone H3F3A (K27M or G34R/V/W) were related to tumor location and prognosis of pediatric gliomas. Clinically, several preclinical and clinical studies…
The achievements in increasing cure rates and disease control for several subtypes of pediatric cancer in the last decades are undeniable. Yet, high-grade astrocytomas (HGA) are a particularly lethal and disabling form of brain cancer, with barely 10% of children and young adults surviving 3 years after their diagnosis. Worldwide efforts in facing this devastating tumor are evolving. Rece…
Medulloblastoma is the most common brain cancer in childhood. The treatment available is surgery, chemiotherapy and radiotherapy. The use of more effective therapy, which grants a greater free disease survival and less later related effects it is very wanted. Thus, the search of new therapeutic targets became very important for childhood treatment. These targets can be related to cellular…
| 5 / 3 | Completed research grants |
| 1 / 1 | Ongoing scholarships in Brazil |
| 4 / 3 | Completed scholarships in Brazil |
| 2 / 2 | Completed scholarships abroad |
| 12 / 9 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID